3D models for osteoarthritis – New test systems for disease modifying research
Osteoarthritis is a debilitating condition that affects millions of people worldwide. It is a progressive disease that can cause pain, stiffness, and reduced mobility, and is caused by the breakdown of cartilage in joints. Osteoarthritis research has traditionally relied on animal models and 2D cell culture systems to study the disease. However, 3D models are emerging as a valuable tool for advancing our understanding of osteoarthritis and developing new therapies.
What is a 3D model?
A 3D model is a three-dimensional structure that mimics the complex architecture of tissues in the human body. These models can be created using various techniques, including bioprinting, scaffold-based methods, and organ-on-a-chip technologies. 3D models can provide a more accurate representation of human biology, enabling improved disease modelling and drug screening.
Advantages of 3D models in osteoarthritis research when compared to 2D cell systems
- Better representation of joint tissue: 3D models can better replicate the complex architecture of joint tissues, enabling improved disease modelling and drug screening.
- Improved cell viability and functionality: 3D models provide a more physiologically relevant environment for cells, leading to improved cell viability and functionality.
- Enhanced drug screening: 3D models enable more accurate drug screening, reducing the need for animal testing and accelerating the drug development process.
- Personalized medicine: 3D models can be created using patient-derived cells, enabling the development of personalized therapies.
- Reduced cost and time: 3D models can be used to rapidly screen potential drug candidates, reducing the time and cost associated with drug development.
Challenges and future directions
While 3D models offer many advantages in osteoarthritis research, there are still significant challenges that need to be addressed.
- Complexity: While 3D cartilage models can replicate some of the complexity of real human cartilage, including the extracellular matrix and cell types, they may not fully capture the complexity of the in vivo environment, such as the presence of other cells and tissues that surround and interact with the cartilage.
- Mechanical properties: Real human cartilage has unique mechanical properties that allow it to absorb and distribute forces. While 3D cartilage models can mimic some of these properties, they may not be an exact replica of real human cartilage in terms of mechanical behaviour.
- Aging and disease: Real human cartilage changes with age and can develop diseases such as osteoarthritis. While 3D cartilage models can be used to study these changes, they may not perfectly replicate the disease process or reflect all the changes that occur in real human cartilage.
Additionally, the high cost and technical expertise required to create and maintain 3D models may limit their widespread use.
In conclusion, 3D models are emerging as a valuable tool in osteoarthritis research. They offer several advantages over traditional animal models and 2D cell culture systems, including better representation of joint tissue, improved cell viability and functionality, enhanced drug screening, and the potential for personalized medicine. While there are still significant challenges to overcome, the continued development of 3D models in osteoarthritis research holds great promise for improving our understanding of the disease and developing new therapies.
Alcyomics’s Osteochondral model has been developed as part of the CRACK IT fund managed by the NC3Rs. Our novel 96 well based 3D tissue system is capable of demonstrating mature ECM deposition and joint maturation in vitro. Stimulation of our model results in matrix remodelling mechanistically similar to osteoarthritis and other inflammatory pathologies of the joint.
Contact us to find out more!